Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.
about
Targeted therapy for HER2 positive breast cancerPolypeptide-based nanogels co-encapsulating a synergistic combination of doxorubicin with 17-AAG show potent anti-tumor activity in ErbB2-driven breast cancer models.Autophagy Protects from Trastuzumab-Induced Cytotoxicity in HER2 Overexpressing Breast Tumor Spheroids.Toward individualized breast cancer therapy: translating biological concepts to the bedside.Physical Intimacy of Breast Cancer Cells with Mesenchymal Stem Cells Elicits Trastuzumab Resistance through Src ActivationA HER2 selective theranostic agent for surgical resection guidance and photodynamic therapy.Deciphering the role of insulin-like growth factor-I receptor in trastuzumab resistance.Molecular Mechanisms of Trastuzumab-Based Treatment in HER2-Overexpressing Breast CancerCytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients.Adaptive Immune Responses and HER2/neu Positive Breast Cancer.p130Cas scaffold protein regulates ErbB2 stability by altering breast cancer cell sensitivity to autophagy.Expression of transmembrane protein 26 (TMEM26) in breast cancer and its association with drug response.Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancerSeptin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.Mucolytic Agents Can Enhance HER2 Receptor Accessibility for [(89)Zr]Trastuzumab, Improving HER2 Imaging in a Mucin-Overexpressing Breast Cancer Xenograft Mouse Model.Integrin α3β1-CD151 complex regulates dimerization of ErbB2 via RhoA.N-Acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imagingPI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy.Mechanisms for DNA-damaging agent-induced inactivation of ErbB2 and ErbB3 via the ERK and p38 signaling pathways.Current Therapies for Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Patients.
P2860
Q26830496-B3A3C460-B66B-42F3-BFE2-3A176B388C4DQ35602561-471E135A-16AA-4647-9A26-4288204C9D0CQ35770542-512619F8-ABD4-465D-996A-D323D4F561DDQ35913199-ECE73082-786B-4682-8BE3-7E5D153F5C41Q36034029-68B663DF-E053-47F3-946D-203FBFA869D2Q36097775-62BB5D2C-4C8D-4139-B791-567978E870EFQ36102124-297E81DB-82E0-4662-A417-308A3244B4E1Q36440214-0E668F4D-041B-4F84-87E7-F53FB272AA10Q36554684-D82E0C0E-38CB-4510-A5D7-F83D44EB8AE4Q36607857-01F7FBFF-93EA-4B49-8ECD-22C4A2D7949CQ36782465-3C9FFD12-BCF4-4C5F-9625-87C7510079E3Q37437522-7A3A5A15-DA85-46AB-A113-5E372B575863Q37588298-38964179-F304-435E-996F-32DEE4306BD3Q38780521-2F8F0B03-9213-4B88-AB80-149E58081B49Q38901000-318D8493-3EDF-4B74-B358-11C113643A25Q39136410-D2DF454B-E3AE-4CF0-AD61-38CFF206D7A1Q41347430-311F6C14-73E2-4A07-BC47-16A3AA612CD7Q44585456-1E852B99-406A-4FB0-B85D-EC5970413386Q50053731-8C354960-2DCC-4A60-B62F-51332E06A74CQ52578959-9395BBF2-4634-4A95-BF81-42F9C39B6A25
P2860
Mechanisms of Trastuzumab resistance in ErbB2-driven breast cancer and newer opportunities to overcome therapy resistance.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@ast
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@en
type
label
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@ast
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@en
prefLabel
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@ast
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@en
P2093
P2860
P356
P1476
Mechanisms of Trastuzumab resi ...... o overcome therapy resistance.
@en
P2093
Haitao Luan
Hamid Band
Mayumi Naramura
Robert J Clubb
Srikumar M Raja
Tameka A Bailey
Vimla Band
P2860
P356
10.4103/1477-3163.90442
P407
P577
2011-11-30T00:00:00Z